TRACER PHARMA ApS: Financial statements 2016
CVR: 34090106
Source: annual report 2016, Danish Business Authority
01/05/2015 – 30/04/2016
TRACER PHARMA ApS (CVR 34090106) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 3,105,057 and a net result of DKK 123,002 compared with DKK 30,108 the year before. That is an increase of 43.2% compared with the year before. Equity in the 2016 report amounted to DKK 207,089. The solvency ratio was 6.1%.
- Gross Profit
- DKK 3,105,057
- Profit/Loss
- DKK 123,002
- Equity
- DKK 207,089
- Total Assets
- DKK 3,387,867
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 3.1 mio. | 123 t. | 207 t. | - |
| 2015 | - | 2.2 mio. | 30 t. | 114 t. | - |
| 2014 | - | 2 mio. | 123 t. | 204 t. | - |
Official annual report
Find more companies like TRACER PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout TRACER PHARMA ApS
TRACER PHARMA ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2011. The company has been dissolved on 28 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 5,203,816 and a net result of DKK 687,871 compared with DKK 1,705,344 the year before. Equity in the 2025 report amounted to DKK 867,174.